Thu, April 14, 2022
Wed, April 13, 2022
Tue, April 12, 2022
Mon, April 11, 2022
Sun, April 10, 2022
Fri, April 8, 2022
Thu, April 7, 2022

Etzer Darout Maintained (CCCC) at Buy with Decreased Target to $20 on, Apr 11th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-20-on-apr-11th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Etzer Darout of BMO Capital, Maintained "C4 Therapeutics, Inc." (CCCC) at Buy with Decreased Target from $57 to $20 on, Apr 11th, 2022.

Etzer has made no other calls on CCCC in the last 4 months.



There are 2 other peers that have a rating on CCCC. Out of the 2 peers that are also analyzing CCCC, 1 agrees with Etzer's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Derek Archila of "Wells Fargo" Initiated at Hold and Held Target at $25 on, Thursday, February 10th, 2022


This is the rating of the analyst that currently disagrees with Etzer


  • Eric Joseph of "JP Morgan" Initiated at Buy and Held Target at $43 on, Thursday, March 10th, 2022

Publication Contributing Sources